A ruthenium–oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy

Ruthenium complexes have emerged as a promising class of compounds for use as photosensitizers (PSs) in photodynamic therapy (PDT) due to their attractive photophysical properties and relative ease of chemical alteration. While promising, they generally are not inherently targeting to disease sites...

Descripción completa

Detalles Bibliográficos
Autores principales: McKenzie, Luke K., Flamme, Marie, Felder, Patrick S., Karges, Johannes, Bonhomme, Frederic, Gandioso, Albert, Malosse, Christian, Gasser, Gilles, Hollenstein, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729177/
https://www.ncbi.nlm.nih.gov/pubmed/35128412
http://dx.doi.org/10.1039/d1cb00146a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729177/
https://www.ncbi.nlm.nih.gov/pubmed/35128412
http://dx.doi.org/10.1039/d1cb00146a

Ejemplares similares